Skip to main content

Table 1 Costs, in the 1st and 2nd year and their sum after the initial primary care consultation, of use of medications and of subsequent physician visits and the average number (n) of courses of medication, further visits and tests experienced by a patient in each diagnostic category

From: Health-care cost reduction resulting from primary-care allergy testing in children in Italy

Cost items Cost (€) year Mean number of episodes in categories a1 to a12
  1 st 2 nd sum a1 a2 a3 a4 a5 a6 a7 a8 a9 a10 a11 a12
Initial allergy test 12 12 24 0 0 0 0 0 0 1(0)e 1(0) 1(0) 1(0) 1(0) 1(0)
Subsequent sIgE tests 8.8 8.5 17.3 0 0 0 0 0 0 10(0) 10(0) 10(0) 0(0) 0(0) 0(0)
Antihistamine use 182a 177 359 0.56 0.44 0.60 0.43 0.43 0.19 0 0.62 0.50 0 0.20 0.09
Corticosteroids use 730b 709 1439 0.44 0.38 0.40 0.48 0.37 0.10 0 0.23 0.25 0.67 0 0.11
Bronchodilators use 64c 62 126 0.11 0.28 0.40 0.33 0.31 0.05 0 0.10 0.25 0 0.10 0.04
Visit Primary care 65 63 128 0.56 0.63 0.60 0.52 0.52 0.29 0 0.60 1 0.33 0.20 0.38
Visit to allergist 65 63 128 0.11 0.24 0 0 0.17 0.05 0 0.32 0.50 0 0.10 0.16
  1. a Based on 1 tablet ceterizin per day for 1 year
  2. b Based on fluticason, 125-250 mg, 4 puffs/day
  3. c Based on salbutamol and fenoterol, 100 mg, 4 puffs/day
  4. dCosts in 2ndyear were discounted to correspond to 1st year (rate:3%)
  5. eNo tests were performed during 2nd year